ZIMVV ZIMVIE INC

ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

ZimVie to Present at the 41st Annual J.P. Morgan Healthcare Conference

WESTMINSTER, Colo., Dec. 28, 2022 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced that management will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Vafa Jamali, President and Chief Executive Officer, is scheduled to present on Wednesday, January 11, 2023, at 3:00 p.m. Pacific Time. Interested parties may access a live and archived version of the webcast of the presentation at: .

About ZimVie

ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a comprehensive portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet to breathe new life, dedicated energy, and strategic focus to its portfolio of trusted brands and products. From its headquarters in Westminster, Colorado, and additional facilities around the globe, the company serves customers in over 70 countries worldwide with a robust offering of dental and spine solutions including differentiated product platforms supported by extensive clinical evidence.

For more information about ZimVie, please visit us at . Follow @ZimVie on , , , or .

Media Contact Information:



ZimVie

Laura Driscoll •

(774) 284-1606

Investor Contact Information:

Gilmartin Group LLC

Marissa Bych •



EN
28/12/2022

Underlying

ZIMVVZIMVIE INC

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ZIMVIE INC

 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED

ZimVie Stockholders Vote to Approve Acquisition by ARCHIMED PALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the “Merger”) pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 20, 2025 (the “Merger Agreement”). The parties now expect the Merger to close on October 20, 2025, subject to the satisfaction of all conditio...

October 10, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Reports Second Quarter 2025 Financial Results

ZimVie Reports Second Quarter 2025 Financial Results Recently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per shareNet Sales from Continuing Operations of $116.7 millionNet Loss from Continuing Operations of $(3.8) million; Net Loss margin of (3.3)% Adjusted EBITDA[1] from Continuing Operations of $17.5 million; Adjusted EBITDA[1] margin of 15.0%GAAP diluted EPS from Continuing Operations of $(0.14) and adjusted diluted EPS[1] from Continuing Operations of $0.26 PALM BEACH GARDENS, Fla., July 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a g...

July 30, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 202...

ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025 PALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter 2025 and file its Quarterly Report on Form 10-Q after market close on Wednesday, July 30, 2025. On July 21, 2025, ZimVie issued a press release announcing ZimVie’s entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”) for $19.00 in cash pe...

July 25, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Announces Exclusive Distribution Agreement with Osstem Implant ...

ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China Strategic Partnership Provides Market Presence in Growing Chinese Market PALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant Co., Ltd. (“Osstem Implant”), a leading dental solutions provider specializing in high-quality implants and integrated dental technologies globally. The agreement expands ZimVie’s ...

July 23, 2025 1 EN
 PRESS RELEASE
Free
ZIMVV ZIMVIE INC

ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $...

ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash Transaction expected to close by year-end 2025 PALM BEACH GARDENS, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (“ZimVie”) (Nasdaq: ZIMV), a global life sciences leader in the dental implant market, today announced their entry into a definitive agreement pursuant to which ZimVie will be acquired by an affiliate of ARCHIMED (“ARCHIMED”), an investment firm focused exclusively on healthcare industries. Under the terms of the merger agreement, ZimVie stockholders will receive $19.00 in...

July 21, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch